Status: Recruiting
Long-term Follow-up of Subjects Treated With CAR T Cells
This is a single site, non-randomized, open-label, long-term safety and efficacy follow-up study for Phase 1 studies that evaluate the safety and efficacy of CAR T cells: NCT05660369 (DF/HCC# 22-175) and NCT06026319 (DF/HCC# 23-474).
Participants needed: 45
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Marcela V. Maus, M.D.,Ph.D.Updated: Mar 16, 2026Locations: 1
Eligibility criteria
Provision of voluntary written informed consent by subject [+1]